Elizabeth Logers, MD, PhD, discusses the implications of ovarian toxicity on female patients of reproductive age being treated with nirogacestat for desmoid tumors.
Elizabeth Loggers, MD, PhD
Elizabeth Loggers, MD, PhD, is an associate professor in the Clinical Research Division at Fred Hutch Cancer Center.
Articles by Elizabeth Loggers, MD, PhD
Elizabeth Loggers, MD, PhD, medical oncologist, Seattle Cancer Care Alliance, discusses the role that she expects immunotherapy will play in the future treatment landscape of sarcoma.
Latest Updated Articles
The Role of Immunotherapy in the Future Treatment Landscape of SarcomaNovember 12th 2016
